(NASDAQ: IVA) Inventiva Sa's forecast annual revenue growth rate of 1.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Inventiva Sa's revenue in 2024 is $23,451,063.On average, 3 Wall Street analysts forecast IVA's revenue for 2024 to be $256,007,211, with the lowest IVA revenue forecast at $183,704,977, and the highest IVA revenue forecast at $331,595,910. On average, 1 Wall Street analysts forecast IVA's revenue for 2025 to be $252,805,014, with the lowest IVA revenue forecast at $252,805,014, and the highest IVA revenue forecast at $252,805,014.
In 2026, IVA is forecast to generate $1,197,874,425 in revenue, with the lowest revenue forecast at $1,197,874,425 and the highest revenue forecast at $1,197,874,425.